Altimmune Ownership | Who Owns Altimmune?
Altimmune Ownership Summary
Altimmune is owned by 55.27% institutional investors, 0.82% insiders, and 43.91% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.66% of ALT shares. CT (Lux) American Smaller Com 9U USD is the top mutual fund, with 4.40% of its assets in Altimmune shares.
ALT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Altimmune | 55.27% | 0.82% | 43.91% |
Sector | Healthcare Stocks | 57.43% | 9.41% | 33.16% |
Industry | Biotech Stocks | 69.02% | 8.92% | 22.06% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 6.16M | 8.66% | $44.41M |
Ameriprise financial | 5.25M | 7.39% | $37.89M |
Vanguard group | 4.43M | 6.23% | $31.95M |
State street | 3.47M | 4.88% | $25.02M |
Tang capital management | 2.75M | 3.87% | $19.83M |
Geode capital management | 1.66M | 2.33% | $11.96M |
Bellevue group | 945.45K | 1.33% | $6.82M |
Ubs group | 719.55K | 1.01% | $5.19M |
Dimensional fund advisors lp | 633.44K | 0.89% | $4.57M |
Two sigma investments, lp | 605.30K | 0.85% | $4.36M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Gerber | 281.78K | 1.48% | $2.03M |
Tang capital management | 2.75M | 1.31% | $19.83M |
Beirne wealth consulting services | 294.46K | 0.77% | $2.12M |
Kraematon investment advisors | 30.79K | 0.22% | $221.96K |
Bellevue group | 945.45K | 0.13% | $6.82M |
Brown wealth management | 50.00K | 0.13% | $360.50K |
Summit financial wealth advisors | 99.49K | 0.13% | $640.70K |
Wealth effects | 32.85K | 0.08% | $236.85K |
Hennion & walsh asset management | 205.59K | 0.07% | $1.48M |
Gsa capital partners llp | 82.96K | 0.04% | $598.00K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ameriprise financial | 5.25M | 0.01% | 1.38M |
Blackrock funding, inc. /de | 6.16M | 0.00% | 693.21K |
Ubs group | 719.55K | 0.00% | 437.10K |
Millennium management | 345.64K | 0.00% | 241.48K |
Invesco | 247.09K | 0.00% | 215.38K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Capital fund management | - | - | -726.83K |
Vanguard group | 4.43M | 0.00% | -552.25K |
Susquehanna group, llp | 500.92K | 0.00% | -426.04K |
Goldman sachs group | 526.17K | 0.00% | -406.65K |
D. e. shaw | 459.83K | 0.00% | -298.17K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Colony group | 122.54K | 0.00% | 122.54K | $883.51K |
Marshall wace, llp | 65.52K | 0.00% | 65.52K | $472.38K |
Peak6 | 61.95K | 0.00% | 61.95K | $446.64K |
Baird financial group | 59.44K | 0.00% | 59.44K | $428.56K |
Kraematon investment advisors | 30.79K | 0.22% | 30.79K | $221.96K |
Sold Out
Holder | Change |
---|---|
Capital performance advisors llp | -11.00 |
Advisornet financial | -100.00 |
First command advisory services | -250.00 |
Harbour investments | -310.00 |
Newsquare capital | -500.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 197 | 8.84% | 39,287,627 | -0.54% | 55 | 1.79% | 104 | 25.30% | 41 | -4.65% |
Sep 30, 2024 | 180 | -4.26% | 39,499,260 | -6.80% | 55 | 1.56% | 83 | -17.82% | 43 | -6.52% |
Jun 30, 2024 | 188 | 2.73% | 42,381,900 | -4.54% | 59 | 1.04% | 101 | -4.72% | 46 | 12.20% |
Mar 31, 2024 | 183 | 22.00% | 44,397,217 | 33.58% | 75 | 1.98% | 106 | 10.42% | 41 | 78.26% |
Dec 31, 2023 | 150 | 25.00% | 33,236,130 | 9.54% | 61 | 1.73% | 96 | 104.26% | 23 | -41.03% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
CT (Lux) American Smaller Com 9U USD | 3.13M | 4.40% | 794.96K |
Vanguard Total Stock Mkt Idx Inv | 2.24M | 3.15% | - |
CT American Smaller Coms(US) InstAccGBP | 1.95M | 2.74% | 174.76K |
iShares Russell 2000 ETF | 1.85M | 2.60% | -36.16K |
SPDR® S&P Biotech ETF | 1.69M | 2.37% | 12.76K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.12M | 1.58% | 334.00 |
Fidelity Small Cap Index | 721.37K | 1.01% | -5.34K |
Bellevue Healthcare Ord | 600.00K | 0.84% | 600.00K |
iShares Biotechnology ETF | 434.17K | 0.61% | -3.76K |
International Biotechnology Ord | 428.32K | 0.60% | -45.54K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 13, 2025 | WEAVER GREGORY L | Chief Financial Officer | Buy | $52.00K |
Aug 19, 2024 | Drutz David | - | Sell | $56.31K |
Aug 19, 2024 | Drutz David | - | Sell | $54.24K |
Aug 15, 2023 | Drutz David | - | Buy | $862.50 |
Aug 12, 2022 | GILL JOHN | - | Sell | $40.71K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | - | - |
2024 Q3 | - | 2 |
2024 Q2 | - | - |
2024 Q1 | - | - |
ALT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools